Cameras that have been installed in their homes by the CIA, voices that whisper vicious words, and demons that appear in their bedroom at night. These are the delusions and hallucinations of psychosis ...

LONDON (Reuters) - Scientists have identified dozens of genes that work differently in the brains of people with schizophrenia, a finding that could narrow the search for new drugs to treat the ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

People with mental illnesses such as schizophrenia, depression or bipolar disorder die on average 10 to 20 years earlier than the general population. The main causes of this are cardiovascular and ...

Add Yahoo as a preferred source to see more of our stories on Google. The hand of Laura Stertz, a research scientist, is shown near a sample of mini brain organoids at the UTHealth Houston Brain ...

How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in Science Advances has identified higher levels of two biological markers in ...

Novel study by researchers at the Rambam Health Care Campus could help 21 million people worldwide suffering from the severe ...

—A new study suggests that long-term use of antipsychotic medications may be linked to an increased risk of breast cancer among women with schizophrenia. The reasons for this, however, aren’t clear.

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...